Device / Technology News

RSS

Novel method could help advance fight against persistent 'HIV latency'

Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection-by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

12 Sep 2012

Scripps scientists discover new antibody-discovery technique

Scientists at The Scripps Research Institute have found a new technique that should greatly speed the discovery of medically and scientifically useful antibodies, immune system proteins that detect and destroy invaders such as bacteria and viruses. New methods to discover antibodies are important because antibodies make up the fastest growing sector of human therapeutics; it is estimated that by 2014 the top-three selling drugs worldwide will be antibodies.

12 Sep 2012

iPad app revolutionising therapy for autistic children

Australian researchers have harnessed tablet technology to develop an iPad app that is set to revolutionise the way parents around the world provide in-home therapy for their autistic children.

12 Sep 2012

Pfizer, Visterra collaborate to discover novel antibodies

Visterra Inc., developer of novel therapeutics to treat major diseases, announced today that it has entered into a collaboration agreement with Pfizer to discover novel antibodies using Visterra's proprietary platform.

11 Sep 2012

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.

11 Sep 2012

FDA clears Covidien’s LigaSure technology for ENT procedures

Covidien, a leading global provider of healthcare products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat (ENT) procedures.

11 Sep 2012

DATATRAK announces technology and services agreement with Bellicum

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a multi-million dollar, five-year technology and services agreement with Bellicum Pharmaceuticals.

11 Sep 2012

Acacia subsidiary obtains patent for stent graft technology

Acacia Research Corp announced today that a subsidiary has acquired a patent for stent graft technology.

11 Sep 2012

Dynamic process modeling can deal with patients who fail to keep appointments

A problem faced by patients seeking medical attention is often getting a clinic appointment at a time convenient to them. Conversely, cancellations and more crucially "no-shows" by patients can disrupt the day-to-day scheduling of a medical practice leading to frustration for patients and staff alike as well as affectively efficiency in a negative manner and leading to lost revenue.

11 Sep 2012

Dengue vaccine breakthrough

Results of the first ever trial to show that a safe and effective dengue vaccine may be possible are published Online First in The Lancet.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Blood flow simulation tools can test and optimize Berlin Heart design

Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients' outcomes.

11 Sep 2012

New method can measure methyl mercury at unprecedentedly small concentrations

A strip of glass covered in hairy nanoparticles can cheaply and conveniently measure mercury, which attacks the nervous system, and other toxic metals in fluids.

11 Sep 2012

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Technology developed by scientists at The Methodist Hospital Research Institute could halve the time it takes to diagnose tuberculosis infection, and also tell doctors in a day or two whether the bacteria are drug resistant -- a process that currently takes weeks. Initial tests of the device were recently described in Scientific Reports, a Nature online journal.

11 Sep 2012

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Providing patient-friendly 3T MR imaging with outstanding image quality, Kaleida Health's Gates Vascular Institute (GVI) in Buffalo, N.Y., installed the Vantage Titan 3T MR system from Toshiba America Medical Systems, Inc., the 1,400th Vantage MR installation worldwide.

11 Sep 2012

Bio DG’s novel metal system receives U.S. patent for use in implantable medical devices

Bio DG announced today that its patent for a novel metal system for use as biodegradable material in developing implantable medical devices was granted by the U.S. Patent Office on August 21, 2012.

11 Sep 2012

Eaton plans to begin development of transdermal patch delivery system for Tropine 3

Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to announce that the Company plans to begin development of a transdermal patch delivery system for Tropine 3, a patent pending novel indication of homatropine for non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women.

11 Sep 2012

Flow cytometry renders PCR testing unnecessary for most AML patients

Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research led by St. Jude Children's Research Hospital investigators has identified the best test for measuring that response and guiding therapy.

11 Sep 2012

New computer system interprets human emotions based on lip pattern

A computer is being taught to interpret human emotions based on lip pattern, according to research published in the International Journal of Artificial Intelligence and Soft Computing. The system could improve the way we interact with computers and perhaps allow disabled people to use computer-based communications devices, such as voice synthesizers, more effectively and more efficiently.

11 Sep 2012

More patients gain weight after joint replacement surgery

Hip and knee replacements are now a common surgical procedure with more than 700,000 total joint arthroplasties (TJAs) performed in the US every year. Due to the reduction in pain and increases in mobility experienced after having a TJA, it could be expected that weight loss may occur as a by-product of the surgery.

10 Sep 2012